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In a recent study (1) of agglutination and absorption of agglutinin 
with strains  of hemolytic streptococcus from scarlet fever and ery- 
sipelas, we found these two groups to be related antigenically.  This 
relationship was peculiar in that the strains within the groups were 
not identical, yet possessed of common antigenic properties.  These 
common  antigenic  properties  were  apparently  not  entirely  group- 
specific, since sera of one group would agglutinate certain strains of 
the other group of streptococci.  When several erysipelas strains and 
their corresponding sera were employed in a  comprehensive series of 
agglutination reactions, in which each of the strains was tested  for 
agglutination  with  each  of  the  sera,  few  negative  reactions  were 
found.  Except with strains which were apparently physically incap- 
able of agglutination, the reactions within the group were consistently 
positive with each strain and serum.  When scaflatinal strains were 
agglutinated with these erysipelas immune sera,  by testing each of 
the  scarlatinal  strains  for agglutination with each of the  sera in  a 
manner similar to the tests carried out with the erysipelas strains, a 
much lower percentage of positive reactions was obtained.  None of 
the strains and none of the sera showed consistently positive reactions. 
A  strain  might agglutinate in one or several of the erysipelas sera. 
A serum might agglutinate one or more of the scarlatinal strains.  The 
antigens of the two groups were apparently related. 
Absorption  of agglutinin has  shown  that  the  strains  within  the 
groups are not identical, since it is not usually possible to absorb the 
agglutinin  for the homologous strain  from serum with heterologous 
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group strains.  However, when a serum is absorbed with an heterolo- 
gous strain of a group, and the absorbing dose is equivalent to the dose 
of the homologous strain necessary for the absorption of the  homolo- 
gous  agglutinin,  all  heterologous  agglutinin  is  removed.  Such  ab- 
sorption not only removes the agglutinin  for heterologous strains  of 
the group represented by the serum, but the agglutinin  for strains  of 
the other group as well.  It is only by excessive and repeated doses of 
the absorbing  antigen under conditions where the agglutinin  is liable 
to  deteriorate  from  long  continued  heating  that  the  homologous 
agglutinin  can  be absorbed by heterologous  group  strains.  Appar- 
ently  the  antigenic  characteristic  of  the  individual  strain  is  para- 
mount while the group characteristics are of secondary importance in 
the bacterial structure. 
The  most  satisfactory explanation  for the  antigenic  relationships 
apparently  existing  between  the  strains  of  the  erysipelas  and  scar- 
]atinal groups, is that  the antigen in each strain is a  mosaic of anti- 
genic fractions which occur in variable amounts in different strains. 
Group specificity would then depend on the presence of characteristic 
fractions some of which might  occur in  certain  strains  of the other 
group.  The predominating fraction would give the strain specificity, 
a characteristic antigen or group of antigens would give group specific- 
ity,  and  the  occurrence  of  one  or  more  of  these  fractions  in  both 
groups  would  explain  the  apparently  existing  relationship  between 
scaflatinal and erysipelas strains. 
We have previously studied the absorption of agglutinin by several 
methods.  In  1924  we  studied  the  scurlatinal  group  (2).  We  at- 
tempted to absorb the agglutinin  for the homologous strain  from  its 
corresponding serum with heterologous scarlatinal  strains.  We were 
able to accomplish our purpose but with certain reservations as far as 
strains  and sera were concerned.  The  following quotation is taken 
from the published article. 
"We have found that certain  combinations of sera and strains are necessary 
for the successful absorption of agglutinin.  These combinations can  usually be 
picked out by the speed of the reaction and the degree of agglutination.  Strains 
wfl] absorb the agglutinin from sera which are fresh if the agglutination is com- 
plete within 15 minutes at 55°C. 
By selecting sera and strains which have reacted  vigorously we have been able 
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These  reactions  were  carried  out  ~dth  doses  of antigen  which  we 
now  consider  excessive  for  absorption  work.  In  an  immediately 
previous article published in 1926  (1)  the dose of antigen employed in 
absorbing the  sera was uniform.  It was a  dose slightly larger than 
that  required  when  the  homologous agglutinin  was absorbed from a 
serum  for  the  corresponding  strain.  With  this  dose  it  was  seldom 
possible to absorb the homologous agglutinin with heterologous strains 
of the  group.  While  these  absorption  tests  demonstrated  what  all 
the  strains  of a  group were not  identical  they did not  indicate  how 
closely the individual strains might resemble each other.  A  series of 
absorption  reactions  has  been  carried  out  in  which  the  sera  were 
absorbed  with  doses  of  antigen  uniformly  and  gradually  increased 
from the unabsorbed serum ("zero" dosage) to the dose necessary for 
the absorption of the  homologous  strain.  , Both  scarlatinal  and  ery- 
sipelas strains have been included so as  to determine  the  relationship 
between the strains in the erysipelas group as well as their relationship 
to those strains of the scarlatinal group which agglutinate in erysipelas 
immune sera. 
Experimental Methods. 
Three  erysipelas immune  sera  and  a  number  of  erysipelas and  scarlatinal 
strains were selected for the agglutination and absorption tests.  The erysipelas 
strains  were chosen without  discrimination  but  scarlatinal strains were picked 
which  agglutinated with  the  three  sera.  Since  agglutination  of each of these 
scarlatinal strains did not occur with all of the sera, the same strains could not be 
employed  throughout  the  experiments.  The  technique  of  immunization  and 
agglutination have been fully described previously (1,  2).  The method of ab- 
sorption also has been described with the exception of the technique for obtaining 
uniform absorptive doses and of the manner in which  the fractional doses were 
estimated. 
The  physical bulk of  streptococci necessary for the subminimal absorption 
of agglutinin was determined for each serum and the homologous strain.  The 
streptococci were grown in broth and centrifuged under uniform conditions in 
especially constructed quantitative centrifuge tubes.  The quantities  necessary 
with each of the sera and the homologous strain were averaged, and this average 
was accepted as the unit absorptive dose of bacteria for a definite volume of serum 
of 1:20 dilution.  Each of the three erysipelas  sera was then absorbed with fractional 
and multiple doses of this unit.  Each of the three sera was absorbed in turn by all 
three strains represented by the immune sera.  After each absorption the sera were 
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The  results of these absorptions  and agglutinations are arranged 
in  Tables  I  to  nI.  Each table  represents  the work with  a  single 
serum.  The absorbing strain is indicated at the head of each broad 
column and the decimal part of the unit absorbing dose employed is 
found at  the left margin.  The numerals at  the intersecting points 
show the degree of agglutination with the absorbed serum and the 
various scaflatinal and  erysipelas strains.  The agglutinations were 
done  in  a  series  of six  dilutions,  1 : 40,  1: 80,  1 : 160,  1: 320,  1 : 640, 
TABLE  I. 
Fractional  Agglutinin  Absorption:  Erysipelas Serum I  Absorbed with Erysipelas 
Strains I, II, and III. 
Absorbed by Strain E I 
1.5 
1.0" 
0.5 
0.45 
0.4 
0.35 
0.3 
0.25 
0.2 
0.15 
0.1 
0.05 
0.0 
Absorbed by Strain E II  Absorbed by Strain E [II 
6 ....  2. 
6----3-3. 
6--2213- 
6--1313- 
6223--4- 
622545 
6 / 2[ 41 6 / 41 4[ 
61 41 41 6 / 6 / 6 I 
6[ 5 / 6[ 6] 6]61 
Absorbing dose 
* Absorbing doses are in fractions and multiples of this unit. 
and 1:1280.  The numerals 1, 2, 3, 4, 5, and 6 indicate respectively 
the last  dilution  in  which agglutination  occurred.  The  scaflatinal 
and erysipelas strains have been indicated by the appropriate letters 
S and E. 
DISCUSSION  AND  SUM.MARY. 
The interpretation  of the results in  these experiments is difficult 
on  account  of  the  variations  in  the  physical  capacity  of  different 
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tinin.  Even when the antigens for agglutination  and absorption are 
standardized and sera are carefully titrated variations in agglutination 
occur with different strains and sera.  Variations may occur because 
of differences in  the titer of the immune sera employed.  In a  large 
series of reactions with the same sera and strains, errors in interpreta- 
tion depending on these factors can be eliminated because strains which 
agglutinate  poorly will consistently give weak reaction with all sera, 
and weak sera will agglutinate  all strains poorly.  After such varia- 
TABLE  II. 
Fractional Agglutinin Absorption:  Erysipelas  Serum II Absorbed By Strains E  I, 
II, and IlL 
Absorb- 
ing 
dose 
1.5 
1.0" 
0.5 
0.45 
0.4 
0.35 
0.3 
0.25 
0.2 
0.15 
0.1 
0.05 
0.0 
Absorbed by Strain E I 
4----32-- 
61---- 
65----6--166-- 
66--16--2651 
661331666 
61  6 /  2  / 3[  6  3  6  6[ 6 I 
6 / 6[  314[  6[ 4 / 6[  6 / 6[ 
6 / 6 / 4 / 51  6 /  41 61 6 / 51 
Absorbed by Strain E I[ 
-i 
i  I 
5J-i- I-  -I 
6]-[  -  I 
i 
611[  - 
6[  31-1-  -I-I-1 
63----  6  3----  31--l--I 
61 61 61 4  61 2  21 
6[  6]  516  6,1  4  4[ 
Absorbed by Strain E nI 
61111  / 
6---  3 
6 
13 
6--13- 
6--34- 
6--244- 
631561 
61314161613 
616151616[3 
--I--[--  -- 
-I 
II  - 
-131-  I 
11411  1 
11  Sf  ~  3 
3141.4 3 
61 61 ~  4 
6161¢  3 
*Absorbing doses are in fractions and multiples of this unit. 
tions  in  agglutination  are  eliminated,  if  a  strain  varies  grossly  in 
agglutination  with different sera,  or the titer of different sera varies 
with the same strain as in Tables I to III, variations which occur must 
represent antigenic dissimilarities. 
We have  previously commented  on  the  dissimilarity  of the  indi- 
vidual strains in the scarlatinal and erysipelas groups.  Although the 
strains within each of the groups are related they are seldom identical. 
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don by heterologous strains failed to  absorb  the agglutinin for the 
strain  homologous  with  the  serum.  This  strain  individuality  is 
again  apparent  in  Tables  I  to  III.  Doses  of heterologous strains 
equivalent to the unit absorptive dose which has already been defined, 
fail to remove the agglutinin for the homologous strain.  This dose is 
sufficient however, to absorb the agglutinin for practically all heterolo- 
gous strains.  It appears from this observation that the strain specific- 
ity dominates the group specificity. 
TABLE  III. 
Fractional Agglutinin Absorption:  Erysipelas Serum Ill Absorbed with Erysipelas 
Strains I, II, and III. 
~.bsorb- 
ing 
dose 
1.5 
1.0" 
3.5 
D.45 
E).4 
~) .35 
0.3 
0.25 
0.2 
0.15 
0.1 
0.05 
0.0 
Absorbed  by  Strain  E I 
i 
3  - 
2  - 
3  - 
3 
3-1-  1 
43--31-- 
53--3 
54--531 
44  1632 
563644 
(64653 
I 
Absorbed  by  S~ain  E U  Absorbed  by  Strain  EIII 
,  m  mm  m 
1 
--  2 
--  2 
--  --  2  -- 
41  I--  ! 
2----123----4-- 
! 
2----3311  21 
412451[  22 
341542  141 
i~  53562[  454 
~ 65454  464 
i  65664  565 
11  .....  1 
32!--14 
21,  14213 
3  4!  2  1  4  3  1  !  1--  5  3il 
53l  44531111443 
45:445  3344i4 
55  ~  6566  4  3  5  4,4l 
* Absorbing doses are in fractions and multiples of this unit. 
Between the unit absorptive dose and a dose which is approximately 
0.2 to 0.3 of this unit, is a  zone of great variation in absorption and 
agglutination.  Below this zone absorption is complete for few strains. 
The differences in  titer of various strains and absorbed sera in  the 
zone where variations occur are very definite.  For example in Table 
II,  Strain E  IX agglutinates well in Serum II absorbed with Strains 
E I and E III but poorly in serum absorbed with Strain EII.  Numer- 
ous similar examples may be found.  In a few instances heterologous 
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absorbed  sera.  Such  strains  probably  resemble  the  homologous 
strains closely.  These resemblances are not confined to the erysipelas 
strains but occur among the scarlet strains which agglutinate in ery- 
sipelas sera.  Apparently it is impossible to distinguish such scarla- 
tinal strains from erysipelas strains by absorption of agglutinin. 
The relationship shown by these absorption tests is additional evi- 
dence in favor of the mosaic nature of the antigen.  Strains of strep- 
tococcus of the erysipelas groups are apparently composed of several 
agglutinogenic fractions.  If the antigen of a strain is made up of the 
fractions A, B, C, D, and E, serum for that strain would contain A, B, 
C, D, and E agglutinins.  If this serum were absorbed with the homol- 
ogous strain or an identical heterologous strain the agglutinin would be 
completely absorbed.  On the other hand a  qualitative or quantita- 
tive difference between the two strains would be apparent in the ab- 
sorption and agglutination reactions.  Such differences are evident in 
Tables I to III.  This serum would agglutinate any strain containing 
any one or several of the fractions, but absorption of the serum by such 
a  strain would leave fractions of the agglutinin in the serum.  This 
absorbed serum would agglutinate  the  homologous strain.  Heter- 
ologous strains would agglutinate if fractions remained in the serum 
corresponding to their antigenic components.  Hence the reactions in 
the absorbed serum would depend on the qualitative and quantita- 
tive relationships between the component fractions in the serum, the 
absorbing strain, and the strains agglutinated. 
This conception of multiple antigens is not new in bacteriology. 
Durham (3)  explained the  reactions in  the  colon-typhoid group of 
bacilli on this basis.  More recently Durand and S6daUian (4), and 
Andrewes, Derick, and Swift (5) have expressed the opinion that  the 
agglutination  reactions with  hemolytic  streptococcus  can  only  be 
accounted for in this way.  In many respects the reactions observed 
with the colon-typhoid group of Gram-negative bacilli resemble those 
experienced with the erysipelas and scarlatinal groups of hemolytic 
streptococcus.  Apparently we  have  exhausted  the  possibilities of 
studying these groups further by agglutination and absorption.  Our 
knowledge regarding the specificity and relationship of the antigenic 
fractions must come from the study of fractions isolated and refined 
by chemical methods. 446  BIOLOGY  OF  STREPTOCOCCUS.  Vl 
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